Results 41 to 50 of about 295,380 (280)

Follicular lymphoma (FL) [PDF]

open access: yes, 2006
Review on Follicular lymphoma (FL), with data on clinics, and the genes ...
Castoldi, GL, Russo, Rossi A, Cuneo, A
core   +1 more source

The Role of miRNAs in Chicken Immune Regulation and Prospects for Disease‐Resistant Breeding

open access: yesAnimal Research and One Health, EarlyView.
A schematic workflow illustrating the screening of disease‐resistant miRNAs and the generation of miRNA‐based disease‐resistant chickens via PGC‐mediated germline genome editing. ABSTRACT MicroRNAs (miRNAs) are emerging as pivotal regulators of the immune system, playing a decisive role in shaping disease resistance in chicken.
Qiangzhou Wang   +10 more
wiley   +1 more source

Case Report: Epstein-Barr virus-positive follicular lymphoma with high PD-L1 expression

open access: yesFrontiers in Immunology
BackgroundFollicular lymphoma is a common B-cell lymphoma and is classified as an indolent lymphoma, more frequently seen in middle-aged and elderly individuals.
Xue Zheng   +4 more
doaj   +1 more source

Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review

open access: yesMolecular Cancer, 2006
Transcriptional silencing of tumor suppressor genes, associated with DNA methylation, is a common epigenetic event in hematologic malignancies. Although DNA hypermethylation of CpG islands is well described in acute leukemias and myelodysplastic ...
Montero Alberto, Hayslip John
doaj   +1 more source

Contained abdominal aortic rupture secondary to follicular lymphoma invasion

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2022
An 87-year-old woman with grade IIIb follicular lymphoma treated with rituximab had presented with nausea, emesis, and chest pain of 1 day duration. She was found to have a contained abdominal aortic rupture secondary to follicular lymphoma invasion. She
Albertina Sebastian, MD   +5 more
doaj   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

open access: yes, 2023
Follicular lymphoma (FL), the most common indolent lymphoma, has a heterogeneous clinical course.1 Positron emission-computerized tomography (PET) using 18F-Fluorodeoxyglucose (18F-FDG) is integral to response assessment in FL.2 The inferior outcomes in ...
Trotman, Judith   +28 more
core   +1 more source

Follicular lymphoma.

open access: yesExperimental oncology, 2012
[No abstract available]
F. De Angelis, FOA, Roberto
openaire   +3 more sources

Homocitrullinated Peptides Drive Pro‐Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Anti‐homocitrullinated protein/peptide antibodies are specific to rheumatoid arthritis (RA) and predictive of worse prognosis, suggesting a pathogenic role for autoreactivity to homocitrullinated peptides (HomoCitP). However, T cell responses to HomoCitP remain largely unexplored.
Sofya Ulanova   +6 more
wiley   +1 more source

Genetic Alterations Impact Immune Microenvironment Interactions in Follicular Lymphoma. [PDF]

open access: yes, 2020
Interactions between germinal center B cells and immune cells in the microenvironment can play integral roles in transformation and growth of follicular lymphoma (FL).
Ochsenbein, Adrian F.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy